---
$id: https://graph.org.ai/products/commodity/51141568
$type: Product
source: UNSPSC
code: "51141568"
title: "Morsuximide"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Morsuximide

**UNSPSC Code**: 51141568
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C16H20N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 57G776P4EJ, chemically known as 2,5-pyrrolidinedione, 3-methyl-1-(4-morpholinylmethyl)-3-phenyl- (9ci) but generally known as morsuximide, which bears US NIH Compound Identifier 71165. European Medicines Agency schedules Morsuximide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09072MIG. The term MORSUXIMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). MORSUXIMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule morsuximide under HS 29349990 and SITC 51579. As of Q4 2014, MORSUXIMIDE remains the US FDA Preferred Term for this commodity. Morsuximide bears US NLM identifiers UMLS ID C1881904 and NCI Concept Code C66202. SMILES: O1CCN(CN2C(=O)C(CC2=O)(C2CCCCC2)C)CC1.

